Jubilant Life reported a consolidated net profit of ₹260.49 crore for the quarter ended on 31 March 2020 as against a net loss of ₹100.65 crore for the corresponding period of the previous fiscal Drug firm Jubilant Life Sciences on Friday reported a consolidated net profit of ₹260.49 crore for the quarter ended on 31 March 2020, driven by robust sales in pharmaceuticals segment.
The company had posted a net loss of ₹100.65 crore for the corresponding period of the previous fiscal, Jubilant Life Sciences said in a filing to BSE.
Consolidated revenue from operations stood at ₹2,391.41 crore for the quarter under consideration as against ₹2,385.58 crore for the same period year ago, it added.
Read more on livemint.com